Because of its high infectivity and pathogenicity, Mycobacterium tuberculosis is a serious threat to human health. While the transcription-regulatory system of M. tuberculosis remains incompletely understood, Rv0081, an essential regulatory hub, is known to mediate the initial response to hypoxia in the longterm survival of M. tuberculosis. Here, the production, crystallization and initial X-ray crystallographic analysis of Rv0081 are reported. The crystals of Rv0081 belonged to space group P6 2 , with unit-cell parameters a = 67.48, b = 67.48, c = 40.84 Å , = 120 . The Matthews coefficient is 2.09 Å 3 Da À1 , assuming the presence of one molecule in the asymmetric unit, with a corresponding solvent content of 41.27%. Phasing of the native crystal form of Rv0081 was performed by molecular replacement. Currently, the structure has been refined to 2.00 Å resolution with an R work of 25.99% and an R free of 30.88%. research communications Acta Cryst. (2017). F73, 281-285 Dong et al. Mycobacterium tuberculosis Rv0081 285
Introduction
Tuberculosis (TB) has become one of the top ten causes of death worldwide. In 2015, the World Health Organization reported that 10.4 million people fell ill with TB and 1.8 million people died from the disease (including 0.4 million people with HIV; World Health Organization, 2015) . Its ability to persist in infected individuals without producing any symptoms for very long periods of time makes Mycobacterium tuberculosis (MTB) an extremely successful pathogen. Therefore, it is important to understand the mechanisms that regulate the survival of latent MTB.
Latent MTB can adapt to potentially harmful stress within the host by regulating specific gene expression. Transcriptome analysis has identified critical regulators of gene expression, such as the cholesterol regulator KstR (Kendall et al., 2007) , the virulence lipid anabolism regulator WhiB3 (Singh et al., 2009) and the well known hypoxia regulator DosR (Voskuil et al., 2004; Park et al., 2003) . While the regulatory mechanisms underlying these and other adaptations are largely unknown, adaptations to hypoxia play a prominent role in the survival and pathogenesis of MTB (Galagan et al., 2013) .
The locus Rv0081-Rv0088 encodes the components of a predicted formate hydrogenylase enzyme complex that is directly regulated by MprA and DosR/DevR. Rv0081, the product of the first gene in this operon, negatively regulates its own expression by binding to an inverted repeat element in the upstream region of the locus (He et al., 2011 ). An MTB
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# 2017 International Union of Crystallography regulatory network study reported that Rv0081 is the only regulator in the initial hypoxic response apart from DosR. Rv0081, which is linked to lipid metabolism, cholesterol metabolism, protein degradation and the initial hypoxic response, forms the largest hub and interacts with other hubs in the network model (Galagan et al., 2013) . Additionally, some experiments have verified Rv0081 as an important transcription factor that may be involved in the regulation of hypoxia (Ruan et al., 2016) . Azizi and coworkers illustrated that Rv0081 and DosR are important in the formation of feedforward loops (FFL), mediating the induction of a second hierarchy of regulators with a time delay and leading to a later hypoxic response (Azizi et al., 2014) .
Owing to social systems, levels of economic development and the lack of an effective vaccine for TB , diagnosis of TB remains a challenge in resource-constrained areas. After stimulating whole blood in pulmonary TB patients and household contacts (HHCs) with Rv0081, some specific immune response cytokines (such as IL-12, IP-10, IL-10 and TNF-) show discriminating levels between TB cases and HHCs. Rv0081-specific levels of specific immune response cytokines were the most promising candidates for TB diagnosis (Chegou et al., 2012) . The expression levels of IL-6, IL-10 and TNF-were distinct after stimulating whole blood with four latency antigens (Rv0081, Rv2629, Rv2006 and Rv1733c) in pulmonary TB patients (Kassa et al., 2012) , whereas on stimulation with Rv0081 in TB and non-TB cases only tissue plasminogen activator (tPA) responses were significantly different (Awoniyi et al., 2016) . Rv0081-specific levels of specific immune response cytokines require further research as promising candidates for TB diagnosis.
Currently, the function of Rv0081 is largely unknown in the context of M. tuberculosis gene regulation, pathogenesis and physiology, and no structure of Rv0081 is available in the Protein Data Bank (PDB). The protein is predicted to be a member of the helix-turn-helix (HTH) superfamily according to the NCBI database (https://blast.ncbi.nlm.nih.gov/Blast.cgi).
Here, we present the cloning, expression, purification, crystallization and X-ray diffraction analysis of Rv0081 from M. tuberculosis H37Rv.
Materials and methods

Macromolecule production
Wild-type cDNA for Rv0081 was amplified by PCR using the M. tuberculosis H37Rv genome as a template and was cloned into the plasmid pET-28a-SUMO derived from pET-28a (Novagen). The recombinant plasmid for Rv0081 was transformed into Escherichia coli strain BL21 (DE3) (TransGen Biotech, People's Republic of China) and overexpressed. Freshly transformed cells were cultured at 310 K in 800 ml LB medium containing 50 mg l À1 kanamycin. Once the OD 600 had reached 0.5, the culture was transferred to 289 K. Protein expression was then induced by the addition of 0.5 mM isopropyl -d-1-thiogalactopyranoside (IPTG) for 17 h. The cells were harvested by centrifugation, resuspended in 10 ml lysis buffer (20 mM HEPES, 500 mM NaCl, 5% glycerol pH 7.0) per gram of pellet and frozen at 253 K. The cells were disrupted using a low-temperature ultrahighpressure cell disrupter (JNBIO, People's Republic of China). The lysate was centrifuged at 12 000 rev min À1 for 30 min at 277 K to remove cell debris. The supernatant was then loaded three times onto an Ni-NTA column (GE Healthcare, USA) pre-equilibrated with lysis buffer. The resin was washed four times with 60 ml lysis buffer. The 6ÂHis-SUMO tag was cleaved by incubating the protein with SUMO protease overnight at 277 K. Recombinant Rv0081 was eluted with lysis buffer and buffer-exchanged into initial ion-exchange buffer (20 mM HEPES, 40 mM NaCl pH 7.0) using an Amicon Ultra-15 centrifugal filter unit (Millipore; 10 kDa molecular-weight cutoff). The sample was then further purified using a Resource S column (1 ml; GE Healthcare, USA). The purified protein was exchanged into low-salt buffer (20 mM NaCl, 5 mM DTT pH 7.0), concentrated to 10 mg ml À1 and stored at 193 K. Protein purity was assessed by 15% SDS-PAGE and the protein homogeneity was analysed by sizeexclusion chromatography using a Superdex 200 10/300 GL column (GE Healthcare, USA; Fig. 1 ). Macromoleculeproduction information is summarized in Table 1 .
Crystallization
Initial crystallization trials were performed in a 96-well format using a 1:1 ratio of well solution to protein solution at 6 mg ml À1 by screening at 289 K with commercial crystal screening kits, including Index, Crystal Screen and PEG/Ion from Hampton Research. Small crystals of Rv0081 ( Fig. 2a ) first appeared after 2 d in 200 mM zinc acetate dehydrate, 100 mM sodium cacodylate trihydrate pH 6.5, 18%(w/v) PEG 8000. Further optimization by adjusting the pH and the concentrations of PEG 8000 and protein was performed, and the final optimized crystallization conditions were 200 mM zinc acetate dehydrate, 100 mM sodium cacodylate trihydrate pH 6.5, 6%(w/v) PEG 8000 with 3 mg ml À1 Rv0081 using the hanging-drop method (Fig. 2b) . Crystallization information is summarized in Table 2 .
Data collection and processing
Crystals were flash-cooled in liquid nitrogen with reservoir solution containing 20% glycerol as a cryoprotectant. A data set at a resolution of 2.00 Å was collected on BL18U1 at Shanghai Synchrotron Radiation Facility (SSRF). Diffraction data sets were indexed, integrated and scaled using the HKL-3000 suite (Minor et al., 2006) . Data-collection and processing statistics are shown in Table 3 .
Results and discussion
Recombinant Rv0081 was expressed and purified from E. coli BL21 (DE3) cells using a two-step purification protocol (affinity and ion-exchange chromatography). Protein purity was assessed by 15% SDS-PAGE and protein homogeneity was analysed by size-exclusion chromatography. Rv0081 eluted from the Superdex 200 column at 15.9 ml, which is between the elution volumes of -lactoglobulin (molecular mass 35 000 Da) and ribonuclease A (molecular mass 13 700 Da), indicating that Rv0081 is most likely to be a dimer in solution (Fig. 1 ). Initial small crystals were observed in several conditions. After optimization, diffraction-quality crystals (Fig. 2b) acetate dehydrate, 100 mM sodium cacodylate trihydrate pH 6.5, 6%(w/v) PEG 8000 by the hanging-drop method. To verify that the protein had indeed crystallized, several crystals were looped out and washed with the same reservoir. These crystals were then dissolved in low-salt buffer and subjected to 15% SDS-PAGE analysis with Coomassie Brilliant Blue staining, which showed one band corresponding to Rv0081 (Fig. 3) . The best diffraction-quality crystals diffracted to a resolution of 2.00 Å (Fig. 4 ) on BL18U1 at SSRF and belonged to space group P6 2 , with unit-cell parameters a = 67.48, b = 67.48, c = 40.84 Å , = 120 . Analysis of the crystal content using programs from the CCP4 suite (Winn et al., 2011) indicated that there was one molecule in the asymmetric unit, with a Matthews coefficient of 2.09 Å 3 Da À1 and a corresponding solvent content of 41.27%. When the sequence was submitted to a BLASTP protein database search at NCBI, no significant similarity was found in the results. However, Phyre 2 (http:// www.sbg.bio.ic.ac.uk/phyre2/html/page.cgi?id=index) predicted the three-dimensional structure to be extremely similar to that of the ArsR-like transcriptional regulators. We are currently solving the crystal structure of Rv0081 by molecular replacement (MR) using the truncated monomer structure of SmtB from Synechococcus elongatus (PDB entry 1r22; Eicken et al., 2003) as a model with programs from the CCP4 suite (Winn et al., 2011) . After running Phaser-MR, we replaced the model sequence with the object sequence and built the C-terminal amino acids of Rv0081 with 'autobuild/refine' in Buccaneer. Initial refinement resulted in an R work and R free of 32.78 and 43.94%, respectively. The Rv0081 structure was further manually built into the modified experimental electron density using Coot (Emsley & Cowtan, 2004) and refined in PHENIX (Adams et al., 2010) . Currently, the structure has been refined to 2.00 Å resolution with an R work of 25.99% and an R free of 30.88%. Further refinement and model building of the structure is in progress.
Figure 4
X-ray diffraction image from an Rv0081 crystal. 
